Suppr超能文献

甲状腺激素受体α1 突变体在小鼠模型中损害 B 淋巴细胞发育。

Thyroid Hormone Receptor α1 Mutants Impair B Lymphocyte Development in a Mouse Model.

机构信息

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

出版信息

Thyroid. 2021 Jun;31(6):994-1002. doi: 10.1089/thy.2019.0782. Epub 2021 Jan 25.

Abstract

Mutations of the thyroid hormone receptor α () gene cause resistance to thyroid hormone (RTHα). RTHα patients exhibit very mild abnormal thyroid function test results (serum triiodothyronine can be high-normal to high; thyroxine normal to low; thyrotropin is normal or mildly raised) but manifest hypothyroid symptoms with growth retardation, delayed bone development, and anemia. Much has been learned about the molecular actions in TRα1 mutants affecting abnormal growth, bone development, and anemia by using a mouse model of RTHα ( mice). However, it is not clear whether TRα1 mutants affect lymphopoiesis in RTHα patients. The present study addressed the question of whether TRα1 mutants could cause defective lymphopoiesis. We assessed lymphocyte abundance in the peripheral circulation and in the lymphoid organs of mice. We evaluated the effect of thyroid hormone on B cell development in the bone and spleen of these mice. We identified key transcription factors that are directly regulated by TRα1 in the regulation of B cell development. Compared with wild-type mice, a significant reduction in B cells, but not in T cells, was detected in the peripheral circulation, bone marrow, and spleen of mice. The expression of key transcription regulators of B cell development, such as , , and 5, was significantly decreased in the bone marrow and spleen of mice. We further elucidated that the gene, essential for lineage specification in the early B cell development, was directly regulated by TRα1. Thus, mutations of TRα1 could impair B cell development in the bone marrow via suppression of key regulators of B lymphopoiesis. Analysis of lymphopoiesis in a mouse model of RTHα showed that B cell lymphopoiesis was suppressed by TRα1 mutations. The suppressed development of B cells was, at least in part, via inhibition of the expression of key regulators, , , and 5, by TRα1 mutations. These findings suggest that the mutations of the gene in patients could lead to B cell deficiency.

摘要

甲状腺激素受体 α (TRα) 基因突变导致甲状腺激素抵抗 (RTHα)。RTHα 患者表现出非常轻微的异常甲状腺功能测试结果(血清三碘甲状腺原氨酸可高正常至高;甲状腺素正常至低;促甲状腺激素正常或轻度升高),但表现出甲状腺功能减退症状,伴有生长迟缓、骨骼发育延迟和贫血。通过使用 RTHα ( )小鼠模型,人们对 TRα1 突变体影响异常生长、骨骼发育和贫血的分子作用有了更多的了解。然而,目前尚不清楚 TRα1 突变体是否会影响 RTHα 患者的淋巴细胞生成。本研究旨在探讨 TRα1 突变体是否会导致淋巴细胞生成缺陷。

我们评估了 小鼠外周循环和淋巴器官中的淋巴细胞丰度。我们评估了甲状腺激素对这些小鼠骨骼和脾脏中 B 细胞发育的影响。我们确定了直接受 TRα1 调节的 B 细胞发育的关键转录因子。与野生型小鼠相比, 小鼠外周循环、骨髓和脾脏中的 B 细胞显著减少,但 T 细胞无明显减少。 小鼠骨髓和脾脏中 B 细胞发育的关键转录调节因子如 、 、和 5 的表达显著降低。我们进一步阐明, 基因是早期 B 细胞发育谱系特化所必需的,它直接受 TRα1 调节。因此,TRα1 突变可能通过抑制 B 淋巴细胞发育的关键调节因子来抑制骨髓中的 B 细胞发育。

对 RTHα 小鼠模型的淋巴细胞生成分析表明,TRα1 突变抑制了 B 细胞淋巴细胞生成。TRα1 突变抑制 B 细胞发育,至少部分是通过抑制关键调节因子 、 、 、和 5 的表达。这些发现表明,患者 基因突变可能导致 B 细胞缺乏。

相似文献

本文引用的文献

5
Thyroid hormone receptors and resistance to thyroid hormone disorders.甲状腺激素受体与甲状腺激素抵抗性疾病
Nat Rev Endocrinol. 2014 Oct;10(10):582-91. doi: 10.1038/nrendo.2014.143. Epub 2014 Aug 19.
10
Clinical phenotype and mutant TRα1.临床表型与突变型TRα1
N Engl J Med. 2012 Apr 12;366(15):1451-3. doi: 10.1056/NEJMc1113940.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验